Posted on26 December 2009.
Imagin Molecular Corporation (OTC: IMGM.OB) engages in the manufacture of positron emission tomography (PET) devices; the ownership of PET imaging center; and the diagnosis and treatment of cancer, heart, and neurological diseases.
Read original story